-
Founded in:
1994-08-18 -
Country:
China -
Address:
No. 29, Huixin Road, Binhai Science and Technology Park, Binhai Hi-tech Zone, Tianjin -
Tax NO.:
91120116238991799D -
Registered Funds:
50 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Reboxetine mesylate |
Extract from the above information
More
Extract from the above information |
71620-89-8 | 3 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| CUCURBITACINS |
No specific pharmacological information is provided
More
No specific pharmacological information is provided |
0 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| APRINDINE HCL |
This product belongs to Class Ib antiarrhythmic drugs, inhibits the permeability of cell membrane to Na, but does not promote K outflow. It can slow down the conduction of various parts of the cardiac conduction system, reduce membrane reactivity, increase the excitation threshold, prolong the effective adaptation period of the atrium, atrioventricular node, His-Purkinje system (Purkinjes fibers) and ventricle, and block the forward and reverse conduction of the bypass pathway.
More
This product belongs to Class Ib antiarrhythmic drugs, inhibits the permeability of cell membrane to Na, but does not promote K outflow. It can slow down the conduction of various parts of the cardiac conduction system, reduce membrane reactivity, increase the excitation threshold, prolong the effective adaptation period of the atrium, atrioventricular node, His-Purkinje system (Purkinjes fibers) and ventricle, and block the forward and reverse conduction of the bypass pathway. |
33237-74-0 | 2 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Indapamide |
Extract from the above information
More
Extract from the above information |
26807-65-8 | 29 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Gliquidone |
This product is a second-generation oral sulfonylurea hypoglycemic drug. It is a highly active pancreatic beta cell agent that binds to specific receptors on the pancreatic beta cell membrane and can induce the production of appropriate amounts of insulin to lower blood sugar concentration.
More
This product is a second-generation oral sulfonylurea hypoglycemic drug. It is a highly active pancreatic beta cell agent that binds to specific receptors on the pancreatic beta cell membrane and can induce the production of appropriate amounts of insulin to lower blood sugar concentration. |
33342-05-1 | 8 |